摘要
目的:探讨临床对高危因素中期妊娠患者运用米非司酮配合利凡诺处理的可行性.方法:将近年到我院终止妊娠的56例高危因素中期妊娠患者纳入研究,通过随机对照法等分成两组,对照组28例选择单纯利凡诺处理,观察组28例选择米非司酮配合利凡诺处理,研究两组的临床处理结局.结果:观察组处理后的引产成功率相比对照组明显更高,宫缩起始时间、产程时间明显更短,软产道裂伤发生率明显更低,差异有统计学意义(P<0.05).结论:对高危因素中期妊娠患者运用米非司酮配合利凡诺处理,引产效果理想、安全,更适合加强推广.
AIM: To investigate the feasibility of mifepristone combined with rivanol in terminating intermediate pregnancy with risk factors. METHODS: A total of 56 cases of intermediate pregnant women with risk factors who were admitted to our hospi?tal in recent years were included in this study and divided into two groups through a randomized controlled method, with 28 cases in each group. Patients in the control group were treated by rivanol, while patients in the observation received mifepristone combined with rivanol treatment. Clinical outcomes of the two groups were observed. RESULTS: The success rate of the observation group was significantly higher than that of the control group, contractions started ealier, labor time was significantly shorter, and incidence of soft birth canal laceration was significantly lower. Differences were statistically significant (P<0.05). CONCLUSION: Mife?pristone combined with rivanol is safer in terminating intermediate pregnancy with risk factors, and the effect is better, so it is wor?thy of promotion.
出处
《转化医学电子杂志》
2015年第8期55-56,共2页
E-Journal of Translational Medicine
关键词
高危因素
中期妊娠
米非司酮
利凡诺
可行性
risk factors
intermediate pregnancy
mifepristone
rivanol
feasibility